EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Pulsed‐Field Ablation for Persistent Atrial Fibrillation in EU‐PORIA Registry

Jun Hirokami iD, Kyoung Ryul Julian Chun iD, Stefano Bordignon iD, Shota Tohoku iD, Kars Neven iD, Tobias Reichlin iD, Yuri Blaauw, Jim Hansen iD, Raquel Adelino iD, Alexandre Ouss iD, Anna Füting iD, Laurent Roten iD und 9 weitere

Journal of Cardiovascular Electrophysiology · 2025-08 · 36 (8) · 1710-1720

DOI: 10.1111/jce.16583 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 02.04.2025. Verfasst von Jun Hirokami und 20 weiteren Autor:innen. Beteiligte Einrichtung: Cardioangiologisches Centrum Bethanien, Frankfurt, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The EU-PORIA registry was supported by a research grant from Boston Scientific..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Real‐life data on efficacy and safety of pulsed‐field ablation (PFA) using the pentaspline multi‐electrode catheter in symptomatic atrial fibrillation (AF) patients is still scarce.

Objective

This study aims to assess the efficacy and safety of PFA in patients with persistent AF.

Methods

Data from early commercial use across seven European centers were collected in a registry. To confirm the efficacy and safety of extra pulmonary vein (PV) ablation, patients were categorized into two groups: those undergoing pulmonary vein isolation (PVI) alone and those receiving additional ablation. Procedural and follow‐up data were collected.

Results

The study included 448 patients (347 PVI only, 101 PVI + α ). In the PVI + α group, extra PV ablation included left atrial posterior wall isolation (87%), mitral isthmus ablation (37%), and cavo‐tricuspid isthmus ablation (3%). At 1‐year follow‐up, the PVI only group showed significantly fewer atrial tachyarrhythmia recurrences compared to PVI + α group (69% vs. 56%, p = 0.013). While AF recurrence did not significantly differ (25% vs. 28%, p = 0.713), PVI + α group had a significantly higher atrial tachycardia recurrence (8% vs. 22%, p < 0.001). Major complications occurred in 2.0% versus 1.0% (PVI only vs. PVI + α ), including pericardial tamponade (6 vs. 0; p = 0.345) and stroke (1 vs. 1; p = 0.400).

Conclusions

PVI plus extra PV ablation using a pentaspline PFA catheter is associated with a higher incidence of atrial tachycardia recurrences. For persistent AF, a simpler approach of performing only PVI may be more effective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationPulmonary VeinsHumansRegistriesMaleFemaleMiddle AgedAgedTreatment OutcomeEuropeRecurrenceAction PotentialsTime FactorsHeart RateRisk Factors

Stichwörter der Autor:innen

atrial fibrillationextra pulmonary vein ablationpersistent AFpropensity score matchingpulmonary vein isolationpulsed‐field ablation

Autor:innen und Institutionen

  • Cardioangiologisches Centrum Bethanien, Frankfurt, Germany.
  • Department of Electrophysiology, Alfried Krupp Hospital, Essen, Germany.
  • Department of Medicine, Witten/Herdecke University, Witten, Germany.
  • Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Arrhythmia Unit, Department of Cardiology, Gentofte Hospital, Copenhagen, Denmark.

ORCID-Profile: Jun Hirokami, Kyoung Ryul Julian Chun, Stefano Bordignon, Shota Tohoku, Kars Neven, Tobias Reichlin, Jim Hansen, Raquel Adelino, Alexandre Ouss, Anna Füting, Laurent Roten, Bart A Mulder, Martin H Ruwald, Roberto Mené, Pepijn van der Voort, Nico Reinsch, Thomas Kueffer, Serge Boveda, Boris Schmidt

Förderung

  • The EU-PORIA registry was supported by a research grant from Boston Scientific.

Zitieren

APA

Hirokami, J., Chun, K. R. J., Bordignon, S., Tohoku, S., Neven, K., Reichlin, T., Blaauw, Y., Hansen, J., Adelino, R., Ouss, A., Füting, A., Roten, L., Mulder, B. A., Ruwald, M. H., Mené, R., van der Voort, P., Reinsch, N., Kueffer, T., Boveda, S., …, & Schmidt, B. (2025). Pulsed‐Field Ablation for Persistent Atrial Fibrillation in EU‐PORIA Registry. Journal of Cardiovascular Electrophysiology, 36(8), 1710-1720. https://doi.org/10.1111/jce.16583

Vancouver

Hirokami J, Chun KRJ, Bordignon S, Tohoku S, Neven K, Reichlin T, et al. Pulsed‐Field Ablation for Persistent Atrial Fibrillation in EU‐PORIA Registry. Journal of Cardiovascular Electrophysiology. 2025;36(8):1710-1720. doi:10.1111/jce.16583

BibTeX
@article{Hirokami2025,
  author = {Hirokami, Jun and Chun, Kyoung Ryul Julian and Bordignon, Stefano and Tohoku, Shota and Neven, Kars and Reichlin, Tobias and Blaauw, Yuri and Hansen, Jim and Adelino, Raquel and Ouss, Alexandre and Füting, Anna and Roten, Laurent and Mulder, Bart A and Ruwald, Martin H and Mené, Roberto and van der Voort, Pepijn and Reinsch, Nico and Kueffer, Thomas and Boveda, Serge and Albrecht, Elizabeth M and Schmidt, Boris},
  title = {Pulsed‐Field Ablation for Persistent Atrial Fibrillation in EU‐PORIA Registry},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  volume = {36},
  number = {8},
  pages = {1710--1720},
  doi = {10.1111/jce.16583}
}
Kostenlos starten →